TY  - RPRT
TI  - Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
AU  - Wallach, J. D.
AU  - Luxkaranayagam, A. T.
AU  - Dhruva, S. S.
AU  - Miller, J. E.
AU  - Ross, J. S.
PY  - 2018
DO  - 10.1101/447185
UR  - https://www.biorxiv.org/content/10.1101/447185v1
ID  - 10.1101/447185
ER  -